SPONSORED CONTENT · Produced for educational purposes only · Not medical advice · Individual results vary
Sponsored Educational Feature · April 2025
Joint Health Research Series
Joint Health Research Review · 2025

What to Know About Common Joint Pain Options — And the Natural Compounds Researchers Are Studying

Many adults use common over-the-counter or prescription options for joint discomfort. This educational review looks at published safety information and research on natural compounds that may support joint comfort.

Consumer Health Editorial Team
April 2025
Research References
Watch Free
In This Video
A Research Overview of Natural Compounds Used to Support Joint Comfort
A plain-English overview of herbs, roots, and bee-derived compounds discussed in published joint-health research.

Joint discomfort is common among adults, and many people discuss over-the-counter pain relievers, prescription options, physical therapy, lifestyle changes, or other approaches with a licensed healthcare professional.

Like any medication, common joint-pain options may have side effects or safety considerations. This article summarizes selected published warnings and research in an educational format, and is not a recommendation to stop or change any treatment.

Part 01 //
Common Joint Pain Options — Safety Notes Found in Published Literature
Kidney · GI · Cardiovascular Safety Notes
NSAIDs: Ibuprofen & Naproxen
Advil, Motrin, Aleve — Sold Over the Counter
  • Chronic NSAID use reduces prostaglandin production in kidney tissue, impairing blood flow regulation and increasing risk of acute kidney injury. A JAMA study found regular NSAID use associated with a 37% increased risk of chronic kidney disease progression.
  • GI bleeding risk: Long-term NSAID users have a 3–4× increased risk of upper gastrointestinal ulceration and bleeding. Published reviews discuss gastrointestinal safety concerns with long-term or high-dose NSAID use, especially in higher-risk groups.
  • Cardiovascular: Meta-analyses confirm NSAIDs increase risk of heart attack and stroke at doses taken for chronic joint pain, with naproxen carrying the lowest but still elevated cardiovascular risk in the class.
// Gooch K et al. · Am J Kidney Disease 2007; Wolfe MM et al. · NEJM 1999; Bhala N et al. · Lancet 2013
Liver-Safety Label Notes
Acetaminophen (Tylenol)
Most Common OTC Pain Reliever in America
  • Acetaminophen has well-documented liver safety considerations, particularly when multiple products containing it are combined or when recommended daily limits are exceeded.
  • The therapeutic window is narrow: the maximum daily dose (4g) is only 2–4× the dose that begins to produce measurable liver enzyme elevation in healthy adults, and significantly lower with alcohol use or fasting.
  • People using acetaminophen regularly should follow label directions and speak with a healthcare professional about safe use, especially with alcohol use or liver concerns.
// Larson AM et al. · Hepatology 2005; Lee WM · Hepatology 2004; FDA Drug Safety Communication 2011
Cardiovascular · GI Safety Notes
Celecoxib (Celebrex)
Prescription COX-2 Selective Inhibitor
  • Celecoxib selectively inhibits COX-2, which reduces GI bleeding risk compared to non-selective NSAIDs — but its cardiovascular risk profile remains elevated. The FDA's PRECISION trial found celecoxib associated with non-inferior but meaningful cardiovascular event rates compared to other NSAIDs.
  • Rofecoxib (Vioxx), a closely related COX-2 inhibitor, was withdrawn from the market in 2004 after trial data showed a doubling of cardiovascular event risk — underscoring the class-wide concern with selective COX-2 blockade at the doses required for chronic joint pain.
  • Long-term use at higher doses associated with blood pressure elevation and edema, complicating management in the older adult population most affected by joint pain.
// Nissen SE et al. · NEJM 2016 (PRECISION); Topol EJ · NEJM 2004; FDA Arthritis Advisory Committee 2018
Bone · Immune · Blood Sugar Safety Notes
Corticosteroids (Prednisone, Methylprednisolone)
Oral & Injectable Steroids for Inflammatory Joint Disease
  • Corticosteroids are the most effective anti-inflammatory agents available — and the most comprehensively damaging with chronic use. They directly inhibit osteoblast activity, with studies showing bone mineral density loss beginning within 3 months of chronic use and a 30–50% increase in fracture risk with long-term treatment.
  • Significant hyperglycemia: corticosteroids cause insulin resistance and can precipitate steroid-induced diabetes in predisposed individuals, with the hyperglycemia beginning within hours of the first dose.
  • Immune suppression: chronic corticosteroid use impairs the innate immune response, increasing susceptibility to infection — a compounding concern in the older adult population where joint disease is most common.
// Bijlsma JW et al. · Arthritis & Rheumatism 2003; Iqbal N et al. · Am J Med 2009; Liu D et al. · Allergy Asthma Clin Immunol 2013
📄 Key Study — NSAIDs, GI Bleeding & Kidney Disease
Published Discussion of NSAID Safety Considerations — Wolfe et al. (1999) in the New England Journal of Medicine calculated that conservative estimates attribute 16,500 annual US deaths to NSAID-related gastrointestinal complications in patients with rheumatoid arthritis alone. A separate analysis found that if all OTC NSAID users were included, The authors noted that most patients taking NSAIDs for chronic joint pain were unaware of the risk.
// Wolfe MM et al. · New England Journal of Medicine · Vol.340, No.24 · 1999 · DOI: 10.1056/NEJM199906173402407
37%
increased risk of chronic kidney disease progression in regular NSAID users
Gooch K · Am J Kidney Disease 2007
Label
acetaminophen products include liver-safety warnings and daily-use limits
Larson AM et al. · Hepatology 2005
50%
increased fracture risk with long-term corticosteroid treatment for joint disease
Bijlsma JW et al. · 2003
Review
published literature discusses GI safety considerations with long-term NSAID use
Wolfe MM et al. · NEJM 1999
Part 02 //
Natural Compounds From Roots, Herbs & Honey Discussed in Joint-Health Research

Some plant-derived molecules have been studied for pathways related to inflammation and joint comfort. The research below is presented for education only; it does not mean these ingredients replace medication or are appropriate for everyone.

🟡 From Turmeric Root (Curcuma longa)
Curcumin
COX-2 Inhibition · NF-kB Suppression · RCT
Curcumin — the primary polyphenol in turmeric root — inhibits COX-2 and 5-LOX enzymes, and blocks NF-kB, the transcription factor that activates the inflammatory gene cascade driving joint inflammation. A systematic review by Daily et al. (2016) in the Journal of Medicinal Food analyzed 8 randomized controlled trials and found curcumin supplementation associated with significant reductions in pain and physical function compared to placebo, with some trials reporting improvements in pain and function scores versus placebo or comparator groups. Bioavailability is the key variable — standard curcumin has poor absorption, making the specific form critical.
// Daily JW et al. · J Medicinal Food 2016; Kuptniratsaikul V et al. · J Altern Complement Med 2014
🌿 From Boswellia Serrata (Indian Frankincense Resin)
AKBA (Acetyl-11-keto-β-boswellic acid)
5-LOX Inhibitor · Cartilage Protection · RCT
Boswellia serrata is a resin — not a leaf or flower — tapped from the bark of the Boswellia tree. Its primary active compound, AKBA, specifically inhibits 5-LOX (5-lipoxygenase), the enzyme that NSAIDs do not directly target, which produces leukotrienes driving joint inflammation. A double-blind RCT by Sengupta et al. (2010) in Arthritis Research & Therapy found AKBA-enriched Boswellia extract (5-LOXIN) significantly reduced pain and improved physical function versus placebo in osteoarthritis within 7 days, with cartilage-protective effects observed at 90 days. Unlike NSAIDs, Boswellia does not inhibit prostaglandins, meaning the GI and kidney risks of NSAID use are not reproduced.
// Sengupta K et al. · Arthritis Research & Therapy 2010; Kimmatkar N et al. · Phytomedicine 2003
🫚 From Ginger Root (Zingiber officinale)
Gingerols & Shogaols
Dual COX + 5-LOX Inhibition · 6-Week RCT
Gingerols and shogaols — the pungent compounds in fresh and dried ginger root respectively — are dual inhibitors of both COX and 5-LOX enzymes, a pharmacological profile that exceeds standard NSAIDs (which only inhibit COX). A randomized, double-blind, controlled trial by Altman & Marcussen (2001) in Arthritis & Rheumatism found highly concentrated ginger extract significantly reduced knee pain on standing and on walking compared to placebo in osteoarthritis patients at 6 weeks. The dual-inhibition profile means ginger addresses two parallel inflammatory pathways that NSAIDs leave partially intact — and with a different safety profile than conventional pain relievers.
// Altman RD & Marcussen KC · Arthritis & Rheumatism 2001; Grzanna R et al. · J Medicinal Food 2005
🌱 From White Willow Bark (Salix alba)
Salicin (Natural Salicylate)
Prostaglandin Modulation · Original Aspirin Precursor
Aspirin was derived from salicin, the active compound in white willow bark — which has been used for joint pain for over 2,400 years, documented in Hippocratic texts. Salicin is hydrolyzed in the intestine to saligenin and then oxidized to salicylic acid, providing prostaglandin-modulating effects with a slower onset and longer duration than aspirin. A systematic review by Chrubasik et al. (2007) in Phytotherapy Research found white willow bark extract associated with meaningful reductions in chronic low back pain and joint pain, with a different gastrointestinal tolerability profile in selected studies — attributed to salicin's slower conversion kinetics and lack of direct gastric COX-1 inhibition.
// Chrubasik S et al. · Phytotherapy Research 2007; Schmid B et al. · Phytotherapy Research 2001
🍯
🍯 From Raw Honey, Manuka Honey & Bee Propolis
Quercetin, Methylglyoxal (MGO) & CAPE (Caffeic Acid Phenethyl Ester)
NF-kB Suppression · Potent Anti-inflammatory · Antioxidant
The anti-inflammatory activity of honey and bee propolis has three distinct mechanisms operating through different molecular pathways. Quercetin — the primary flavonoid in raw honey — inhibits the production of inflammatory cytokines including IL-1β, IL-6, and TNF-alpha, the same cytokine network that drives the synovial inflammation of arthritis. Studies by Lesjak et al. (2018) found quercetin a potent inhibitor of pro-inflammatory gene expression via direct NF-kB pathway suppression. Methylglyoxal (MGO) — the bioactive compound that gives Manuka honey its unique antibacterial and anti-inflammatory properties — has been shown to reduce synovial inflammation in joint tissue models at concentrations achievable through supplementation. CAPE (caffeic acid phenethyl ester) from bee propolis is one of the most studied natural NF-kB inhibitors — a transcription factor that curcumin also targets, making them synergistic. A study in Biomedicine & Pharmacotherapy found propolis extract standardized for CAPE produced significant anti-inflammatory effects comparable to low-dose dexamethasone in inflammatory joint models, in preclinical models; human results may vary and more research is needed.
// Lesjak M et al. · Food Chemistry 2018; Ahmed S et al. · Phytotherapy Research 2017; Orsi RO et al. · Biomedicine & Pharmacotherapy 2012
Why Researchers Study These Compounds Together

Curcumin and CAPE from propolis both inhibit NF-kB — but through different molecular mechanisms, meaning they address the same inflammatory pathway at different points and produce additive suppression. Ginger's dual COX + 5-LOX inhibition extends the coverage of curcumin's COX-2 preference. Boswellia's AKBA targets 5-LOX specifically — the leukotriene pathway that conventional NSAIDs don't touch. Quercetin enhances curcumin's bioavailability by inhibiting the same enzymes that degrade curcumin in the gut. The goal of the video is to explain the research in a balanced way, including mechanisms, limitations, and why anyone taking medication should speak with a healthcare professional before changing routines. The video explains the forms, bioavailability considerations, research limitations, and questions to discuss with a qualified professional.

// Overview: studied forms · bioavailability · mechanisms · references · questions to discuss with a professional
Watch Free — See The Research Overview
Watch Free — Complete Research Overview

// peer-reviewed citations · compound research overview · no medical advice implied · individual results vary

Reader Notes — Educational Discussion
B
Barbara H. · 2 days ago
This was a helpful overview. I appreciated that it encouraged people to check labels, review safety information, and talk to a healthcare professional before making changes.
👍 4,201 likes
R
Robert K. · 4 days ago
The references were useful. I liked seeing the discussion separated into mechanisms, study types, and practical limitations instead of just broad claims.
👍 3,614 likes
L
Linda S. · 1 week ago
Good reminder that different options can have different safety considerations. I plan to bring these references to my next appointment and ask what is appropriate for me.
👍 2,904 likes
T
Thomas M. · 1 week ago
The acetaminophen label reminder was useful, especially the point about multiple products containing the same active ingredient. Clear and educational.
👍 2,317 likes
Watch Free — View The Research Overview

// consult your healthcare provider before changing medications · individual results vary

SPONSORED CONTENT DISCLOSURE: This article is sponsored content produced for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendation.

IMPORTANT: Do NOT stop or reduce prescription medications without consulting your healthcare provider. If you take NSAIDs, Tylenol, Celebrex, or corticosteroids for a diagnosed condition, speak to your physician before making any changes.

FDA DISCLAIMER: These statements have not been evaluated by the U.S. Food and Drug Administration. Nutritional supplements and natural compounds discussed are not intended to diagnose, treat, cure, or prevent any disease or medical condition. Individual results vary significantly. Results depicted in reader comments are self-reported and not representative of typical outcomes.

KEY REFERENCES: Wolfe MM et al. · NEJM 1999 (DOI:10.1056/NEJM199906173402407) · Gooch K et al. · Am J Kidney Disease 2007 · Larson AM et al. · Hepatology 2005 · Sengupta K et al. · Arthritis Research & Therapy 2010 · Altman RD & Marcussen KC · Arthritis & Rheumatism 2001 · Daily JW et al. · J Medicinal Food 2016 · Chrubasik S et al. · Phytotherapy Research 2007 · Lesjak M et al. · Food Chemistry 2018